The Hox genes are a family of homeodomain-containing transcription factors which determine anteroposterior identity early on in development. Although a lot is now known about their regulation and function, very little is known of their effector (downstream target) genes. Here we show that the small GTPase Rap1 is a direct, negatively regulated target of Hoxb4 and is excluded from Hoxb4 expressing cells. q
Introduction
A number of molecular components employed in patterning the early embryo have been very highly conserved through evolution, and the Hox genes are a particularly noticeable example. They encode a family of homeodomain transcription factors that are expressed along the anterior to posterior (anteroposterior) axis from the gastrula stage onwards, in a spatial and temporal order that closely reflects their relative position within the chromosome. Their expression defines the anterior-posterior character of those cells which express them, and consequently their deletion or misexpression can cause the transformation of one part of the embryo into another (reviewed by Carroll, 1995; Gehring, 1998; Burke, 2000) .
The control and function of Hox genes have been extensively studied in a wide range of species, and many of the molecular aspects of their regulation are now understood. However, far less is known about the actual molecular basis of Hox gene function. In vitro, most HOX proteins recognize the same four-base-pair consensus sequence that is actually repeated many times in the genome (Hayashi and Scott, 1990) . Far greater binding specificity is achieved when HOX proteins bind as a complex with other proteins, including PBX (vertebrate homologues of Drosophila homeodomain-containing transcription factor extradenticle, Chang et al., 1996) . Thus HOX proteins can recognize considerably more specific sites in vivo, the identity of which have now been tentatively established (Chang et al., 1995 (Chang et al., , 1996 Ryoo and Mann, 1999; White et al., 2000) . In order to understand the molecular basis for Hox gene function, we need to know which genes are the immediate targets of transcriptional activation or repression. However, to date very few of the downstream targets of Hox genes are known.
For this reason we have looked for genes that are directly regulated by the Hox gene Hoxb4. This is the vertebrate homologue of the Drosophila deformed gene which is expressed in and required for the correct specification of a number of cephalic segments. Deformed mutants lack maxillary and mandibular structures, the head having been transformed to thoracic like structures dorsally and deleted ventrally (Merrill et al., 1987) . Studies in the mouse and in the frog (Xenopus) have revealed that Hoxb4 is expressed in the hindbrain and spinal cord, with a sharp boundary in the hindbrain between rhombomeres 6 and 7 (Graham et al., 1988; Godsave et al., 1994) . The homozygous null mutation of Hoxb4 in the mouse results in a homeotic transformation of the second cervical vertebrae from axis to atlas, and defective morphogenesis of the sternum (Ramirez-Solis et al., 1993) . Ectopic expression of Hoxb4 in early Xenopus embryos results in the deletion of structures anterior to where Hoxb4 is usually expressed (i.e. the forebrain, midbrain and hindbrain anterior to rhombomere 7 ).
Here we report that the small GTPase Rap1 is a direct target of Hoxb4 regulation. Hoxb4 represses Rap1 expression in a manner that is independent of protein translation, and may bind to two putative HOXB4 protein binding sites located at the 3 0 end of the Rap1 gene in order to mediate this inhibition.
Results

XRap1 and Hoxb4 have complementary expression patterns in early development
In order to search for downstream targets of Hoxb4, we used a differential display technique to compare gene expression in embryos which had developed from eggs injected with Hoxb4 RNA to that in untreated controls. Our attention was drawn to one transcript in particular because it was absent in Hoxb4 injected embryos (Fig. 1) . We therefore cloned and sequenced the corresponding cDNA from the untreated, control embryos. Conceptual translation of the partial open reading frame encoded in this clone gives a peptide which is 96% identical to the human RAP1 protein, a small GTPase (Pizon et al., 1988) . The only differences in the amino acid sequence of the two proteins are 'conservative' changes (i.e. where the amino acids have very similar biochemical properties). We therefore conclude that the differentially expressed clone encodes the Xenopus homologue of the Human Rap1 gene, and we refer to it here as XRap1 (accession number AY059389).
In order to confirm that XRap1 is indeed repressed by Hoxb4, we injected fertilized eggs with Hoxb4 mRNA and then examined the expression of XRap1 later in development, at the neurula stage (Fig. 2) . Using a similar approach, we also examined the affect that Hoxb1, Hoxb5 and Hoxb9 over-expression have on XRap1 (Fig. 2) . Both Hoxb4 and Hoxb5 result in a striking down-regulation of XRap1, whilst both Hoxb1 (a more anteriorly expressed Hox gene) and Hoxb9 (the most caudally expressed Hoxb gene) have no apparent affect on its expression.
In order to determine whether the apparent mutually exclusive relationship between XRap1 and Hoxb4 is reflected in their expression pattern in the embryo, we used whole-mount in situ analysis to study their expression at a number of different developmental stages (Fig. 3) . The expression of XRap-1 begins early in gastrulation (Fig. 3A) in the dorsal ectoderm (the future neural plate). Hoxb4 expression is detected slightly later in gastrulation in a more restricted pattern, being located at a more posterior and ventral position (Fig. 3B ). XRap1 remains confined to the neural tube during neurulation and is expressed throughout its length, with the exception of those cells that express Hoxb4. A sharp boundary between XRap1 and Hoxb4 expression domains becomes apparent as neurulation proceeds. By the tailbud stage the XRap1 and Hoxb4 domains of expression abut sharply both in the hindbrain just posterior to the otic vesicle (the boundary between rhombomeres 6 and 7; Fig. 3F ), and in the head mesenchyme at the position of the fourth pharyngeal arch.
The repression of XRap-1 by Hoxb4 is direct and independent of protein synthesis
The preceding results indicate that Hoxb4 represses XRap-1 expression, but they do not provide any indication as to whether this repression is direct (i.e. independent of further translation), or indirect. In order to address this, we used a fusion between Hoxb4 and the human glucocorticoid receptor (Hoxb4/GR, Hooiveld et al., 1999) . The glucocorticoid receptor binds the heat shock protein HSP90, preventing it from entering the nucleus. This steric hindrance of nuclear entry is relieved by ligand binding, in this case the glucocorticoid analogue dexamethasone (DEX), which by itself has no discernible effects on Xenopus development (Gammill and Sive, 1997) . Hence the Hoxb4/GR construct confers DEX dependence on the activity of Hoxb4 .
We injected fertilized eggs with Hoxb4/GR RNA and allowed them to develop to the mid-neurula stage. The embryos were then treated with dex in the presence or absence of cycloheximide (CHX), which blocks protein synthesis. We examined the expression of XRap-1 and Hoxb4 by reverse transcription-polymerase chain reaction (RT-PCR) of RNA subsequently extracted from these embryos (Fig. 4) . Hoxb4 positively autoregulates its own expression by a direct mechanism , thus activating the Hoxb4/GR construct should upregulate Hoxb4 expression, even in the presence of cycloheximide, as indeed it does (Fig. 4) .
The activation of Hoxb4/GR by DEX results in a strong down-regulation of XRap1, indeed none can be detected when dex alone is added. There is also a very strong down-regulation of XRap1 when DEX and CHX are added together, although some XRap1 transcript is still detectable. This implies that the down-regulation of XRap1 by Hoxb4 does involve a direct mechanism, at least in part. It should be noted though that this result is complicated slightly by the apparent upregulation of XRap1 by CHX (Fig. 4) , which may counteract Hoxb4 repression to some limited extent.
A HOXB4 consensus binding site present in the XRap1 gene can bind HOXB4 protein and mediate transcriptional repression by Hoxb4
The 3 0 untranslated region (UTR) of the XRap1 gene contains two sites that are very similar to the consensus sequence determined for optimum binding of HOXB4 protein to DNA in vivo (White et al., 2000) (Fig. 5A ). In order to determine whether these sites could mediate transcriptional repression by Hoxb4, we cloned them into a position immediately 3 0 to a luciferase (luc) reporter gene, driven by a SV40 promoter (RP1B41, Fig. 5A ). This promoter drives expression of luc in Xenopus embryos ( Fig. 5B ; Etkin and Balcells, 1985) . Co-injecting Hoxb4 RNA with the RP1B41 construct results in a significant down-regulation of luc activity. As a control, we used site directed mutagenesis to alter the HOXB4 consensus binding sequence in RP1B41. This second construct (RP1B42) is not affected by Hoxb4 co-injection. Additionally, we coinjected RP1B41 with RNA transcribed from a deletion construct of Hoxb4 that lacks its homeodomain (Hoxb4DHD) and has previously been shown not to upregulate Hoxb4 expression . Hoxb4DHD has no significant affect on RP1B41 activity (Fig. 5B) . We also examined whether other Hox genes could also affect the expression of the reporter construct. To this end we also co-injected the RP1B41 construct with Hoxb1, Hoxb5 and Hoxb9 mRNAs (Fig. 5C ). Of these, only Hoxb5 prevents the expression of the reporter gene, a finding that is in agreement with the data in Fig. 2 .
Whilst the above data suggests putative HOXB4 binding site in the XRap1 gene can mediate Hoxb4 repression, they do prove that there is a direct interaction between them. We decided to examine this in vivo by using purified HOXB4 protein, linked to agarose beads via GST (glutathione-Stransferase). We incubated these beads with a PCR product derived from either the RP1B41 or the RP1B42 construct, Fig. 4 . RT-PCR analysis of RNA extracted from control ('untreated') or Hoxb4/GR expressing embryos. The embryos were treated with dexamethasone (DEX) and cycloheximide (CHX), either alone or in combination, as shown. Ef1a is included as a loading control. 2RT, PCR amplification without prior reverse transcription step. The XRap1:Ef1a signal ratio is shown for each sample. containing the putative HOXB4 binding site. After washing, only the RP1B41-derived sequence remained bound to these beads (Fig. 6 ). As a control we also used beads with GST alone or with a deletion construct of Hoxb4 lacking the homeodomain (HOXB4DHD). Neither of these proteins could bind the RP1B41-derived sequence (Fig. 6 ).
Blocking the expression of the endogenous Hoxb4 gene results in a significant increase in XRap1 transcription
The translation of specific mRNAs in the early Xenopus embryo can be prevented by the injection of short DNA sequences that are chemically modified to prevent their degradation by endogenous nucleases ('morpholinos'). Morpholinos are designed to be complementary to the translation start site of the target mRNA, and have recently proved to be extremely effective at blocking the expression of specific target genes (Heasman et al., 2000; Ross et al., 2001 ). We designed a morpholino complementary to the translation start site of Hoxb4 mRNA, together with a control morpholino of the same length and base composition but with a scrambled sequence. These were injected into fertilized eggs, and total RNA was extracted from neurula stage embryos that subsequently developed from them. We used this to examine the expression of XRap1, Hoxb1, Hoxb4 and Hoxb5 by RT-PCR (Fig. 7) . The Hoxb4 morpholino (B4morph) causes a significant down-regulation of the endogenous Hoxb4 gene (Fig. 7, lane 2) , presumably as a result of blocking its auto-regulation . The control morpholino (conmorph) has no affect on Hoxb4 expression. As an additional control on the specificity of the B4morph's specificity we co-injected B4morph with (human) HOXB4 RNA. This prevents the B4morph mediated down-regulation of the endogenous Hoxb4 gene (Fig. 7, lane 4) . The B4morph, but not the conmorph, causes a significant increase in the expression of XRap1. Again, this effect is prevented by co-injection of HOXB4 RNA (Fig. 7) .
Discussion
Regulating XRap1
Here we have shown that the Hox gene Hoxb4 directly represses the expression of a small GTPase, XRap1. Furthermore Hoxb4 and XRap1 have complementary expression patterns, with XRap1 being excluded from those cells which express Hoxb4. It is instead most strongly expressed in the anterior most part of the embryo which is fated to form the forebrain and midbrain.
Rap1 is a member of the Ras superfamily of small GTPases that cycle between a GTP bound (active) and a GDP bound (inactive) form (for a review see Bos et al., 2001) . Their main function is to assemble and activate proteins at the cytoplasmic surface of membranes in response to specific stimuli. The most notable member of this family is Ras itself, with Ras mutations being present in 15% of all human tumours.
Rap1 antagonizes Ras signaling, probably by trapping one of its key effectors, the serine/threonine kinase Raf, in an inactive complex. Like Ras, Rap1 is activated by guanine exchange factors (GEFs) that catalyse the exchange of GDP for GTP, and is inactivated by GTPase activating proteins Fig. 6 . HOXB4 protein can bind the genomic region encoding the 3 0 UTR of XRap1 mRNA. PCR amplified XRap1 DNA, with (RP1B41) or without (RP1B42) the putative HOXB4 binding sequence, was incubated with HOXB4-GST (HOXB4) or GST alone on agarose beads. As a further control, a deletion construct of Hoxb4 (lacking the homeodomain region), was also made as a GST construct and linked to beads (HOXB4DHD). The beads were washed to remove unbound probe and then probe that had bound was eluted. The amount of probe present in the first wash and eluate were determined by gel electrophoresis, as shown. B42/B41, RP1B42 or RP1B41 DNA used in the incubation, respectively. (GAPs), that stimulate the otherwise very slow enzymatic activity of Ras family proteins. Rap1-interacting GEFs are activated either directly or indirectly by a number of intracellular messengers such as cAMP (de Rooij et al., 1998; Kawasaki et al., 1998a) , Ca 21 and diacyl glycerol (DAG) (Kawasaki et al., 1998b; Yamashita et al., 2000; Ebinu et al., 1998) . Far less is actually known about how Rap1 is controlled at the transcriptional level, however. To our knowledge, its repression by Hoxb4 is the first example of control being exerted at the transcriptional level during development.
Rap1 in development
Rap1 mediates a number of cellular processes that are involved in brain development. Most notably, it is essential for neurite outgrowth (York et al., 1998) and integrinmediated cell adhesion (reviewed by Bos et al., 2001 ). Furthermore, mutations in the Drosophila homologue of Rap1 disrupt the normal development of the eye (Karpilow et al., 1989) . It is conceivable that there is a similar requirement for Rap1 in vertebrate eye development, a possibility that is supported by our observation that XRap1 is expressed in the developing eye (Fig. 3) and, further, by a previous study showing that antibodies to b-integrin (a Rap1 effector) block retinotectal projection in Xenopus (Stone and Sakaguchi, 1996) .
Why is XRap1 excluded from the more posterior regions of the embryo? Presumably XRap1 activity may disrupt the normal development of the spinal cord by blocking specific developmental events, or by activating inappropriate ones. Hopefully this will be addressed by XRap1 over-expression studies.
Transcriptional control of Rap1
As discussed above, Rap1 is subject to numerous, stringent controls at the post-translational level. What is the likely significance of the very stringent transcriptional control we observe in early development? This is another question which is worthy of investigation. One possibility though is that, unlike the situation in the adult organism (or the cell lines from which they are derived), the complex post translational controls on Rap1 activity have yet to be established. It may be then, that they only way to ensure the 'silence' of XRap1 in Hoxb4 expressing cells is to prevent its transcription.
Hox downstream targets
Identifying the downstream targets of Hox genes is necessary if their function in development is to be understood in molecular terms. XRap1 joins a very short list as to date very few Hox targets have been identified, and those which have tend to come from some what disparate systems. Furthermore, it is not always clear whether the identified targets are actually under the direct control of the Hox gene in question. Table 1 lists some of the Hox gene targets that have been identified in vertebrates (excluding the Hox genes themselves, which are subject to extensive auto-and cross-regulation (Gerard et al., 1996; Gould et al., 1997; Nonchev et al., 1997; Sharpe et al., 1998; Hooiveld et al., 1999) ). The data is striking only for the lack of any apparent sequence or functional similarity between targets, and hints at an enormous complexity of downstream target control. In the light of the recent development of far more powerful techniques for detecting changes in gene expression, such as microarray analysis, it is slightly surprising that the list of Hox targets has grown so little. It is our hope that future studies will continue to address this fascinating problem.
Materials and methods
Differential display analyses
Fertilized Xenopus eggs were injected with 500 pg of Hoxb4/GR RNA. Dexamethasone was added at either stage 7 or 11, and the embryos were then allowed to develop until stage 17. At this point total RNA was extracted and Tkatchenko et al., 2001 Hoxa-9, a-10, b-9, c-9, d-10 1 Ren-1(c) Renin Pan et al., 2001 1mg was used to make cDNA by reverse transcription using a poly-deoxythymidine primer (T15). Two percent of this reaction was then randomly amplified by PCR using a single primer (5 0 -CAG ATT GGT GCT GGA TAT GC-3 0 ), with two rounds of amplification at 94 8C for 30 s, 45 8C for 30 s and 72 8C for 60 s, and then 30 rounds of amplification at 94 8C for 30 s, 60 8C for 30 s and 72 8C for 60 s. The PCR products were resolved by electrophoresis on 2% agarose for 4 h at 200 V (4 8C) and visualized by ethidium bromide staining. Differentially displayed bands of interest were cut out the gel and the PCR products were extracted by Qiaquick PCR Purification kit (Qiagen) and eluted in 50 ml water. The purified PCR products were PCR-re-amplified and gel-purified if necessary, cloned into pGEM-T easy vector (Promega), and sequenced.
RNA extraction and RT-PCR
Total RNA was extracted from whole embryos using the QuickPrep Total RNA extraction kit (Amersham Pharmacia Biotech Inc.). 3 mg of RNA was used in subsequent reverse transcription reactions. This was mixed with a poly T 15 oligo to 5 mg/ml and heated to 75 8C for 5 min. After cooling on ice, the following additional reagents were added; dNTPs to 0.4 mM, RNase OUT (Promega) to 1.6 units/ml, Moloney Murine Leukemia Virus Reverse Transcriptase (MMLRvT) RnaseH 2 point mutant (Promega) to 8 units/ml and the appropriate buffer (supplied by the manufacturer) to 1£ concentration. The mixture was incubated for 1 h at 37 8C, heated to 70 8C for 2 min and cooled on ice.
PCR reactions were all performed in a total volume of 40 ml. For each we used 1 ml of the M-MLRvT reaction (as described above), 0.2 nmol of each primer and 20 ml of Redimix pre-mixed PCR components (Sigma). All reactions were cycled at 94 8C for 30 s, 60 8C for 30 s and 72 8C for 60 s. Thirty cycles were used for all primer sets except those for ef1a , for which 23 cycles were used. The primers used for XRap1 amplification were: forward -XRAP1U: 5 0 -GAT ATG CTG GGG GTG AAG CC-3 0 and reverse -
The sequences of the other primer pairs can be found on the internet at http://www.sghms.ac.uk/depts/anatomy/ pages/richhmpg.htm/
Embryo culture and microinjection
These were performed as described previously (Sive et al., 2000) .
Whole-mount in situ hybridization
XRap1 was cloned into vector pGEMT-easy (Promega), and this was linearized using HindIII. A fluorescein-labelled in situ probe was transcribed from this template using SP6 polymerase. A DIG-labelled Hoxb4 probe was transcribed as previously described (Godsave et al., 1994) . Probe purification and subsequent double probe in situ analysis were performed as described (Sive et al., 2000) , using BCIP alone for XRap1 detection and then NBT/BCIP to detect Hoxb4.
Luciferase reporter constructs
The putative HOXB4 binding sequences in the XRap1 3 0 UTR region were cloned into the XbaI site of the pGL3 luciferase reporter construct (Promega), immediately 3 0 to the luc reading frame (Fig. 5) . In order to do this, the following oligos were synthesized: RP1B4 1 U 5 0 -CTAGT GATTT GTATG TGATT AAGTG-3 0 ; RP1B4 1 D 5 0 -CTAGC ACTTA ATCAC ATACA AATCA-3 0 ;
RP1B4 2 U 5 0 -CTAGG GACCT GTATG GGACC AAGTG-3 0 ; RP1B4 2 D 5 0 -CTAGC ACTTG GTCCC ATACA GGTCC-3 0 . Each of these four oligos were phosphorylated in separate reactions using polynucleotide kinase (PNK), using the protocol recommended by the manufacturer, and then the two (1) and (2) oligos were annealed by mixing half of each PNK reaction together, heating to 90 8C for 5 min and then cooling on ice. The annealed RP1B41 and RP1B42 oligos were then ligated into pGL3 which had been restricted with XbaI, dephosphorylated using calf intestinal phosphatase (Promega), and purified using the Concert PCR purification system (Life Technologies). RP1B41 and RP1B42 clones were selected that contained only one copy of the insert, and these were checked by sequencing. The chosen clones were then purified using the Plasmid Midi kit (Qiagen). RP1B42 and RP1B41 were injected into fertilized Xenopus eggs (100 pg in 5 nl), using the further refinements described by Mayor et al. (1993) . Luciferase activity was measured as previously described .
4.6. In vitro HOXB4 protein/Rap1 DNA interaction A HOXB4/GST fusion protein was made by cloning the full-length Hoxb4 reading frame into the pGEX-2TK vector (Amersham Pharmacia Biotech); further deletion constructs were then made from this base. The fusion proteins were produced and purified according to the manufacturers instructions (GST purification module, Amersham Pharmacia Biotech). XRap1 DNA was added to the purified proteins (still attached to the agarose beads), and incubated for 5 min at room temperature in 50 mM NaCl, 2 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 and 5 mM HEPES buffer (pH 7.4). Each of the DNAs tested were present at a final concentration of 1pg/ml, yeast tRNA was also added to a final concentration of 1 mg/ml.The beads were washed ten times in binding buffer (5 min each) and the bound RNA eluted by adding TE buffer and heating for 5 min at 50 8C.
Cycloheximide and dexamethasone treatments of Hoxb4/GR injected embryos
These were performed as described (Gammill and Sive, 1997) . Embryos were incubated with cycloheximide for 30 min prior to the addition of dexamethasone. RNA was extracted from embryos 2 h after dexamethasone treatment, by which point the untreated control embryos had reached stage 17.
